Unpacking Themis Medicare's Q2 FY2026 Performance: A Closer Look

Well, it's always interesting to look at how companies are faring, and Themis Medicare recently released its standalone financial results for the September 2025 quarter. And, honestly, it seems they've had a bit of a bumpy ride this time around.

Let's start with the top line, shall we? The company's net sales for the quarter came in at Rs 77.99 crore. Now, that's a figure that might catch your eye, but here's the crucial detail: it represents a pretty significant dip, specifically down by 21.69% compared to what they managed in the very same quarter last year. It's a noticeable contraction, which certainly sets the tone for the rest of the report.

Moving on to profitability, the picture, unfortunately, gets a little starker. Themis Medicare's quarterly net profit stood at Rs 15.65 crore. And here's where the substantial shift comes in: that's a rather sharp decline of 59.25% year-on-year. To put it simply, they earned considerably less than half of what they did a year ago in terms of net profit. That's a figure that would surely grab any investor's attention.

This trend of decline also extends to other key operational metrics. Their EBITDA, which stands for Earnings Before Interest, Tax, Depreciation, and Amortisation, was reported at Rs 19.33 crore. This, too, marked a substantial fall, down by 54.89% when compared to the corresponding period of the previous fiscal year. It really reinforces the idea that the quarter presented some genuine operational headwinds for the company.

And, as one might expect, the Earnings Per Share (EPS) for September 2025 mirrored these financial shifts. It settled at Rs 17.18, showing a 59.27% drop from the previous year's EPS. So, whether you look at sales, profits, or per-share earnings, it's quite clear that Themis Medicare navigated a challenging period in the September 2025 quarter. It will be interesting to see how they plan to address these figures in the upcoming periods.